Trials, publications and grants since Nov 2024.
Publication
Similar Long-Term Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Initiating Entecavir Versus Tenofovir Alafenamide: A REAL-B Study.
Journal of viral hepatitis, Nov 2026
Publication
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.
Liver international : official journal of the International Association for the Study of the Liver, Aug 2026
Publication
Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology, Jul 2026
Publication
Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions.
Liver international : official journal of the International Association for the Study of the Liver, Jul 2026
Publication
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.
The American journal of gastroenterology, Jun 2026
Publication
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.
Journal of gastroenterology and hepatology, May 2026
Publication
Ablation-Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology, May 2026
Publication
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models.
Alimentary pharmacology & therapeutics, May 2026
Publication
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Hepatology research : the official journal of the Japan Society of Hepatology, Apr 2026
Publication
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.
Hepatology research : the official journal of the Japan Society of Hepatology, Apr 2026
Publication
Lymphocyte-Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab.
Liver international : official journal of the International Association for the Study of the Liver, Apr 2026
Publication
Prospective Study of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Based on Hepatobiliary Phase of Gd-EOB-DTPA-MRI.
Hepatology research : the official journal of the Japan Society of Hepatology, Mar 2026
Publication
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.
Liver international : official journal of the International Association for the Study of the Liver, Mar 2026
Publication
Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study.
Hepatology research : the official journal of the Japan Society of Hepatology, Feb 2026
Publication
Guidance for Liver Rehabilitation in Chronic Liver Disease.
Hepatology research : the official journal of the Japan Society of Hepatology, Jan 2026
Publication
Effect of Butyrate-Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab.
JGH open : an open access journal of gastroenterology and hepatology, Jan 2026
Publication
Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child-Pugh Class B: A Real-World Study.
Hepatology research : the official journal of the Japan Society of Hepatology, Jan 2026
Publication
Effect of Partial Splenic Embolization on Immune Environment and Hepatic Function in Cirrhosis Patients With Portal Hypertension.
In vivo (Athens, Greece), Jan 2026
Publication
Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus.
The American journal of gastroenterology, Dec 2025
Publication
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease.
Hepatology research : the official journal of the Japan Society of Hepatology, Nov 2025
Publication
Clinical Utility of a Prognostic Scoring System Based on LDH and CRP in HCC Patients Receiving Atezolizumab Plus Bevacizumab.
Liver international : official journal of the International Association for the Study of the Liver, Oct 2025
Publication
Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis.
Hepatology research : the official journal of the Japan Society of Hepatology, Aug 2025
Publication
Vascular Invasion Within the Resectability Criteria Is a Prognostic Factor in Patients Treated With Atezolizumab and Bevacizumab.
Liver international : official journal of the International Association for the Study of the Liver, Aug 2025
Publication
Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.
Liver international : official journal of the International Association for the Study of the Liver, Jul 2025
Publication
Comparison of Surgical Resection and Radiofrequency Ablation for Early-Stage HCC Patients With Child-Pugh Class B.
Journal of gastroenterology and hepatology, May 2025
Publication
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit.
JCO clinical cancer informatics, May 2025
Publication
Impact of time-of-day atezolizumab plus bevacizumab combination therapy infusion for unresectable hepatocellular carcinoma: A retrospective multicenter study.
Hepatology research : the official journal of the Japan Society of Hepatology, Feb 2025
Publication
Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCC.
Journal of gastroenterology and hepatology, Jan 2025
Publication
Evaluation of hepatitis B virus reactivation prevention measures in immunosuppressed patients: current status and effectiveness.
Translational gastroenterology and hepatology, Jan 2025
Publication
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.
Cancer medicine, Jan 2025